CLARUS THERAPEUTICS HOLDINGS, INC.: cost_of_revenue

Value{"amount": 2720000, "concept": "us-gaap:CostOfGoodsAndServicesSold", "currency": "USD"}
Period2021-01-01 – 2021-12-31
Statuscurrent
EntityCLARUS THERAPEUTICS HOLDINGS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-22-092120 · Open the official SEC filing →
Retrieved: 2026-08-19T18:16:51.640354+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001817944/cost-of-revenue/2021-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/4137dda8-bd6a-4b22-862c-39d81da32d03

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies